Literature DB >> 16457954

Tolerance development to Morris water maze test impairments induced by acute allopregnanolone.

S Türkmen1, M Löfgren, V Birzniece, T Bäckström, I-M Johansson.   

Abstract

The progesterone metabolite allopregnanolone, like benzodiazepines, reduces learning and impairs memory in rats. Both substances act as GABA agonists at the GABA-A receptor and impair the performance in the Morris water maze test. Women are during the menstrual cycle, pregnancy, and during hormone replacement therapy exposed to allopregnanolone or allopregnanolone-like substances for extended periods. Long-term benzodiazepine treatment can cause tolerance against benzodiazepine-induced learning impairments. In this study we evaluated whether a corresponding allopregnanolone tolerance develops in rats. Adult male Wistar rats were pretreated for 3 days with i.v. allopregnanolone injections (2 mg/kg) one or two times a day, or for 7 days with allopregnanolone injections 20 mg/kg intraperitoneally, twice a day. Thereafter the rats were tested in the Morris water maze for 5 days and compared with relevant controls. Rats pretreated with allopregnanolone twice a day had decreased escape latency, path length and thigmotaxis compared with the acute allopregnanolone group that was pretreated with vehicle. Pretreatment for 7 days resulted in learning of the platform position. However, the memory of the platform position was in these tolerant rats not as strong as in controls only given vehicle. Allopregnanolone treatment was therefore seen to induce a partial tolerance against acute allopregnanolone effects in the Morris water maze.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16457954     DOI: 10.1016/j.neuroscience.2005.12.031

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  14 in total

1.  Allopregnanolone concentration and mood--a bimodal association in postmenopausal women treated with oral progesterone.

Authors:  Lotta Andréen; Inger Sundström-Poromaa; Marie Bixo; Sigrid Nyberg; Torbjörn Bäckström
Journal:  Psychopharmacology (Berl)       Date:  2006-05-25       Impact factor: 4.530

2.  Comparing the discriminative stimuli produced by either the neuroactive steroid pregnanolone or the benzodiazepine midazolam in rats.

Authors:  Xiang Bai; Lisa R Gerak
Journal:  Psychopharmacology (Berl)       Date:  2010-10-23       Impact factor: 4.530

3.  Low brain allopregnanolone levels mediate flattened circadian activity associated with memory impairments in aged rats.

Authors:  Olivier George; Monique Vallée; Sergio Vitiello; Michel Le Moal; Pier-Vincenzo Piazza; Willy Mayo
Journal:  Biol Psychiatry       Date:  2010-05-14       Impact factor: 13.382

Review 4.  Tolerance to allopregnanolone with focus on the GABA-A receptor.

Authors:  Sahruh Turkmen; Torbjorn Backstrom; Goran Wahlstrom; Lotta Andreen; Inga-Maj Johansson
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

5.  Tolerance to the rate-increasing and not rate-decreasing effects of pregnanolone in rats.

Authors:  Amy K Eppolito; Lisa R Gerak
Journal:  Behav Pharmacol       Date:  2010-12       Impact factor: 2.293

6.  Quantitative analyses of antagonism: combinations of midazolam and either flunitrazepam or pregnanolone in rhesus monkeys discriminating midazolam.

Authors:  Lisa R Gerak; Charles P France
Journal:  J Pharmacol Exp Ther       Date:  2011-12-15       Impact factor: 4.030

7.  A post-training intrahippocampal anxiogenic dose of the neurosteroid pregnenolone sulfate impairs passive avoidance retention.

Authors:  E Martín-García; M Pallarés
Journal:  Exp Brain Res       Date:  2008-07-30       Impact factor: 1.972

Review 8.  Progesterone receptors: form and function in brain.

Authors:  Roberta Diaz Brinton; Richard F Thompson; Michael R Foy; Michel Baudry; Junming Wang; Caleb E Finch; Todd E Morgan; Christian J Pike; Wendy J Mack; Frank Z Stanczyk; Jon Nilsen
Journal:  Front Neuroendocrinol       Date:  2008-02-23       Impact factor: 8.606

Review 9.  Biomarkers of cognitive dysfunction in traumatic brain injury.

Authors:  Zhao-Liang Sun; Dong-Fu Feng
Journal:  J Neural Transm (Vienna)       Date:  2013-08-14       Impact factor: 3.575

10.  Neuroregenerative mechanisms of allopregnanolone in Alzheimer's disease.

Authors:  Ronald W Irwin; Jun Ming Wang; Shuhua Chen; Roberta Diaz Brinton
Journal:  Front Endocrinol (Lausanne)       Date:  2012-01-12       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.